Related Experiment Videos
[Hematopoietic growth factors and anaphylaxis]
Medicina Clinica
|June 12, 1999
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Usefulness of neoadjuvant chemotherapy in non-metastatic muscle-invasive bladder cancer.
Actas urologicas espanolas·2021
Breakthrough cancer pain: review and calls to action to improve its management.
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2020
Active study: undetected prevalence and clinical inertia in the treatment of breakthrough cancer pain (BTcP).
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2018
Oncologist's knowledge and implementation of guidelines for breakthrough cancer pain in Spain: CONOCE study.
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2017
Management of malignant insulinoma.
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2013
[Pharmacoeconomics and cost of cancer drugs].
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria·2010
Foundations for the rational prescription of enteral medical nutrition therapy.
Medicina clinica·2026
Eating disorders.
Medicina clinica·2026
Exploring the potential benefits of allergen immunotherapy beyond respiratory allergy.
Expert opinion on biological therapy·2026
Rituximab remodels the circulating immune landscape in pemphigus vulgaris revealed by high-dimensional immune profiling.
Journal of translational autoimmunity·2026
Bronchoalveolar Lavage Fluid α Amylase Level a Promising Biomarker of Aspiration Syndrome: A Pilot Study.
Infection and drug resistance·2026